Physician

Allan C Honculada, MD

According to 2025 Medicare claims, Allan Honculada, MD (NPI: 1215954169) practices pain management in the Lakeland-Winter Haven, FL market, with the plurality of this provider's patient population coming from Polk, FL. This provider's primary affiliated billing organization is FLORIDA PAIN RELIEF GROUP PLLC (NPI: 1376994608; TIN: 472294513) and primary practice location at 33884-3200.

Honculada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 2,044 HCPCS/CPT codes, and received $120,731 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,701 prescription claims across 851 beneficiaries totaling $236,341 in drug costs, led by Percocet (Oxycodone Hcl/Acetaminophen). 2015 DME data shows 12 claims. Open Payments data shows 55 records totaling $1,302. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $267,320 to $120,731. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$189K$377K2015 Medicare payment: $267,320 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $272,153 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $377,081 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $223,348 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $236,963 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $220,581 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $222,528 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $185,141 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $155,568 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $120,731 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154264,543$267,320
20164264,286$272,153
20174358,523$377,081
20183488,894$223,348
20193289,692$236,963
20202599,227$220,581
20212297,342$222,528
20221985,739$185,141
20232264,011$155,568
20241782,044$120,731

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$125K$249K2015 Drug cost: $205,198 (USD; Tot_Drug_Cst)2016 Drug cost: $203,962 (USD; Tot_Drug_Cst)2017 Drug cost: $249,491 (USD; Tot_Drug_Cst)2018 Drug cost: $219,910 (USD; Tot_Drug_Cst)2019 Drug cost: $214,638 (USD; Tot_Drug_Cst)2020 Drug cost: $208,439 (USD; Tot_Drug_Cst)2021 Drug cost: $210,252 (USD; Tot_Drug_Cst)2022 Drug cost: $214,140 (USD; Tot_Drug_Cst)2023 Drug cost: $212,615 (USD; Tot_Drug_Cst)2024 Drug cost: $236,341 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154354,082$205,198
20165084,597$203,962
20175895,649$249,491
20186145,592$219,910
20196346,038$214,638
20206196,486$208,439
20216416,211$210,252
20225775,948$214,140
20237605,466$212,615
20248515,701$236,341

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.5K$9.1K2015 Medicare payment: $9,052 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151212$9,052
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0481Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms6370$153
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more115347$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more123363$67
80307Testing for presence of drug, by chemistry analyzers88108$61
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg77590$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PercocetOxycodone Hcl/Acetaminophen25629$77,834
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,19334,736$36,230
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,61447,035$35,125
FentanylFentanyl762,280$12,063
Oxycodone HclOxycodone Hcl64519,018$11,593

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.55$1,302Nalu Medical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allan C. Honculada, MD?

Tedicare shows public-source Medicare data for Allan C. Honculada, MD (NPI 1215954169), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan C. Honculada, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allan C. Honculada, MD?

Allan C. Honculada, MD is linked to FLORIDA PAIN RELIEF GROUP PLLC (billing NPI 1376994608) in the available physician profile data.

Does Allan C. Honculada, MD have Open Payments data?

Allan C. Honculada, MD has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.